PBYI
Puma Biotechnology, Inc.
NASDAQ · USHealthcareBiotechnology
$8.30-2.70%
Price as of Jul 20, 2026
PBYI capital
Puma Biotechnology, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.12x
- Net debt / equity
- -0.16x
- Debt / assets
- 0.08x
- Debt / EBITDA
- 0.36x
- Net debt / EBITDA
- -0.45x
Liquidity & coverage
- Current ratio
- 2.38x
- Quick ratio
- 2.24x
- Cash ratio
- 1.70x
- Interest coverage
- 5.70x
- EBITDA / interest
- 8.68x
- Working capital
- $82.5M
Cash & dividend
- FCF / debt
- 3.36x
- Cash flow / debt
- 3.36x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.